The company operates a textile trading business selling products like bed sheets and uniforms, while simultaneously liquidating legacy real estate assets and land development rights in Mumbai.
The company lacks a structural competitive advantage, evidenced by chronic operating losses and a negative net margin of -66.4%. While management cites brand value in textiles, the financial results show no pricing power or scale advantage, with revenue declining and returns on equity near zero.
Capital allocation is focused on liquidating investments and property to fund persistent operating losses and dividend payments. Reinvestment in the core trading business has failed to generate positive returns, and the company relies on inter-corporate deposits and asset sales to maintain liquidity.
The company's slow-motion liquidation reached its logical conclusion as the core trading business continued to bleed cash, with negative net margins and declining revenues eroding the remaining asset base. Management exhausted the proceeds from property sales and liquid investments to fund operating deficits and executive pay rather than productive growth. By year five, the 'other income' dried up, the inter-corporate deposits became unrecoverable, and the market finally realized that a business which destroys 66 cents for every dollar of revenue is not a turnaround candidate, but a terminal value trap.
RichFakir rates Standard Industries Ltd's business quality as poor — 11/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Standard Industries Ltd is trading about 61% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Standard Industries Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Standard Industries Ltd's fair value is about ₹41 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →